BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
-0.94%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$498M
AUM Growth
+$498M
Cap. Flow
-$127M
Cap. Flow %
-25.45%
Top 10 Hldgs %
75.53%
Holding
33
New
4
Increased
9
Reduced
10
Closed
4

Top Buys

1
BPMC
Blueprint Medicines
BPMC
$13.8M
2
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
$10M
3
FATE icon
Fate Therapeutics
FATE
$9.44M
4
INFI
Infinity Pharmaceuticals, Inc.
INFI
$3.66M
5
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.79M

Top Sells

1
CASC
Cascadian Therapeutics, Inc.
CASC
$67.5M
2
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
$54.9M
3
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
$15.9M
4
ARRY
Array Biopharma Inc
ARRY
$13M
5
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
$10.2M

Sector Composition

1 Healthcare 76.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$91.3M 18.35% 3,255,280 +490,200 +18% +$13.8M
CYTK icon
2
Cytokinetics
CYTK
$4.23B
$58.9M 11.84% 4,851,691 -145,380 -3% -$1.77M
CCXI
3
DELISTED
ChemoCentryx, Inc.
CCXI
$57.7M 11.59% 7,798,572 -265,447 -3% -$1.96M
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
$43.8M 8.81% 4,986,186 -1,475,000 -23% -$13M
CNCE
5
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$26.9M 5.41% 2,616,249 -106,961 -4% -$1.1M
XENE icon
6
Xenon Pharmaceuticals
XENE
$2.98B
$23.4M 4.71% 3,043,805 -65,100 -2% -$501K
FWP
7
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$20.8M 4.19% 1,387,853 – –
CTIC
8
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$18.1M 3.63% 44,796,940 – –
CLCD
9
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$17.6M 3.54% 484,335 -278,965 -37% -$10.2M
CBIO
10
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$17.2M 3.46% 2,826,282 +400,000 +16% +$2.44M
OMED
11
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$13.6M 2.73% 1,760,489 -51,516 -3% -$397K
CASC
12
DELISTED
Cascadian Therapeutics, Inc.
CASC
$13.5M 2.71% 3,133,224 -15,666,144 -83% -$67.5M
INFI
13
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$10.6M 2.13% 7,860,808 +2,711,164 +53% +$3.66M
ACHN
14
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$10M 2.01% +2,423,300 New +$10M
FATE icon
15
Fate Therapeutics
FATE
$120M
$9.44M 1.9% +3,759,398 New +$9.44M
ARQL
16
DELISTED
Arqule Inc
ARQL
$9.32M 1.87% 7,400,128 – –
ESPR icon
17
Esperion Therapeutics
ESPR
$448M
$8.92M 1.79% 712,770 +218,898 +44% +$2.74M
KDNY
18
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$8.5M 1.71% 745,886 +244,731 +49% +$2.79M
IMDZ
19
DELISTED
Immune Design Corp.
IMDZ
$7.26M 1.46% 1,320,164 +120,164 +10% +$661K
CTMX icon
20
CytomX Therapeutics
CTMX
$336M
$6.1M 1.23% 554,806 -37,007 -6% -$407K
ONCT
21
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5.85M 1.18% 1,108,433 -10,403,567 -90% -$54.9M
VIRX
22
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5.04M 1.01% 1,392,720 +662,359 +91% +$2.4M
ALPN
23
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$4.18M 0.84% 1,864,474 +154,801 +9% +$347K
PVLA
24
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$2.61M 0.52% 1,854,768 +838,175 +82% +$1.18M
SAVA icon
25
Cassava Sciences
SAVA
$110M
$1.3M 0.26% 2,278,552 – –
1
2